Echo Therapeutics (ECTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 176 | 34 | 1,500 | 0 | 0 |
| Cost of Goods | 252 | 17 | N/A | N/A | N/A |
| Gross Profit | -76 | 17 | 1,500 | N/A | N/A |
| Operating Expenses | 6,102 | 5,480 | 4,006 | 4,191 | 3,505 |
| Operating Income | -5,927 | -5,446 | -2,506 | -4,191 | -3,505 |
| Interest Expense | 18 | 0 | 0 | 0 | 1,238 |
| Other Income | 208 | 86 | 27 | 34 | 18 |
| Pre-tax Income | -5,737 | -5,360 | -2,480 | -4,156 | -4,725 |
| Net Income Continuous | -5,737 | -5,360 | -2,480 | -4,156 | -4,725 |
| Net Income | $-5,737 | $-5,360 | $-2,480 | $-4,156 | $-4,725 |
| EPS Basic Total Ops | -25.90 | -34.00 | -65.00 | -70.00 | -212.00 |
| EPS Basic Continuous Ops | -25.83 | -31.97 | -26.19 | -67.44 | -203.33 |
| EPS Diluted Total Ops | -25.90 | -34.00 | -65.00 | -70.00 | -212.00 |
| EPS Diluted Continuous Ops | -25.83 | -31.97 | -26.19 | -67.44 | -203.33 |
| EBITDA(a) | $-5,687 | $-5,290 | $-2,351 | $-4,043 | $-2,152 |